$AIMD - Ainos Unveils AI Nose Breakthrough that Re
Post# of 40253
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company" , a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT" and VELDONA low-dose interferon therapeutics, today announced that its AI Nose has made a significant breakthrough in factory automation with 79% accuracy in detecting 761 samples across 22 different volatile organic compounds (VOCs). https://finance.yahoo.com/news/ainos-unveils-...00402.html
#nasdaq #stockstowatch #stockstobuy #AIMD @charles